Thu, November 9, 2023

Mayank Mamtani Maintained (ALT) at Strong Buy with Decreased Target to $8 on, Nov 9th, 2023

Mayank Mamtani of B. Riley Securities, Maintained "Altimmune, Inc." (ALT) at Strong Buy with Decreased Target from $15 to $8 on, Nov 9th, 2023.

Mayank has made no other calls on ALT in the last 4 months.



There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Mayank's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mayank


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $15 on, Monday, August 14th, 2023
  • Jonathan Wolleben of "JMP Securities" Reiterated at Buy and Held Target at $15 on, Wednesday, July 12th, 2023